Literature DB >> 25044928

Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints.

James C Root1, Elizabeth Ryan, Gregory Barnett, Charissa Andreotti, Kemi Bolutayo, Tim Ahles.   

Abstract

OBJECTIVE: While forgetfulness is widely reported by breast cancer survivors, studies documenting objective memory performance yield mixed, largely inconsistent, results. Failure to find consistent, objective memory issues may be due to the possibility that cancer survivors misattribute their experience of forgetfulness to primary memory issues rather than to difficulties in attention at the time of learning.
METHODS: To clarify potential attention issues, factor scores for Attention Span, Learning Efficiency, Delayed Memory, and Inaccurate Memory were analyzed for the California Verbal Learning Test-Second Edition (CVLT-II) in 64 clinically referred breast cancer survivors with self-reported cognitive complaints; item analysis was conducted to clarify specific contributors to observed effects, and contrasts between learning and recall trials were compared with normative data. Performance on broader cognitive domains is also reported.
RESULTS: The Attention Span factor, but not Learning Efficiency, Delayed Memory, or Inaccurate Memory factors, was significantly affected in this clinical sample. Contrasts between trials were consistent with normative data and did not indicate greater loss of information over time than in the normative sample.
CONCLUSIONS: Results of this analysis suggest that attentional dysfunction may contribute to subjective and objective memory complaints in breast cancer survivors. These results are discussed in the context of broader cognitive effects following treatment for clinicians who may see cancer survivors for assessment.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CVLT-II; cancer; memory

Mesh:

Year:  2014        PMID: 25044928      PMCID: PMC4530580          DOI: 10.1002/pon.3615

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  25 in total

1.  A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.

Authors:  Angela Stewart; Catherine Bielajew; Barbara Collins; Matthew Parkinson; Eva Tomiak
Journal:  Clin Neuropsychol       Date:  2006-02       Impact factor: 3.535

2.  Better preservation of memory span relative to supraspan immediate recall in Alzheimer's disease.

Authors:  Barbara J Cherry; J Galen Buckwalter; Victor W Henderson
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

3.  International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

Authors:  Jeffrey S Wefel; Janette Vardy; Tim Ahles; Sanne B Schagen
Journal:  Lancet Oncol       Date:  2011-02-25       Impact factor: 41.316

4.  Cognition in perimenopause: the effect of transition stage.

Authors:  Miriam T Weber; Leah H Rubin; Pauline M Maki
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

5.  Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature.

Authors:  Cay Anderson-Hanley; Marne L Sherman; Raine Riggs; V Bede Agocha; Bruce E Compas
Journal:  J Int Neuropsychol Soc       Date:  2003-11       Impact factor: 2.892

Review 6.  Renaming "chemobrain".

Authors:  Arti Hurria; George Somlo; Tim Ahles
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

Review 7.  Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

Authors:  Heather S L Jim; Kristin M Phillips; Sari Chait; Leigh Anne Faul; Mihaela A Popa; Yun-Hsiang Lee; Mallory G Hussin; Paul B Jacobsen; Brent J Small
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

8.  Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.

Authors:  Christina M Schilder; Petronella C Eggens; Caroline Seynaeve; Sabine C Linn; Willem Boogerd; Chad M Gundy; Louk V Beex; Frits S Van Dam; Sanne B Schagen
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

9.  Alzheimer's dementia: performance on parallel forms of the dementia assessment battery.

Authors:  E L Teng; C Wimer; E Roberts; A R Damasio; P J Eslinger; M F Folstein; L E Tune; P J Whitehouse; E L Bardolph; H C Chui
Journal:  J Clin Exp Neuropsychol       Date:  1989-12       Impact factor: 2.475

Review 10.  Do aromatase inhibitors have adverse effects on cognitive function?

Authors:  Kelly Anne Phillips; Karin Ribi; Richard Fisher
Journal:  Breast Cancer Res       Date:  2011-02-23       Impact factor: 6.466

View more
  14 in total

1.  Impact of transcranial direct current stimulation on sustained attention in breast cancer survivors: Evidence for feasibility, tolerability, and initial efficacy.

Authors:  Alexandra M Gaynor; Denise Pergolizzi; Yesne Alici; Elizabeth Ryan; Katrazyna McNeal; Tim A Ahles; James C Root
Journal:  Brain Stimul       Date:  2020-04-27       Impact factor: 8.955

Review 2.  Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction.

Authors:  Brenna C McDonald
Journal:  Neurotherapeutics       Date:  2021-08-16       Impact factor: 7.620

3.  Comparison of functional dorsal attention network alterations in breast cancer survivors before and after chemotherapy.

Authors:  Chao-Yu Shen; Yuan-Hsiung Tsai; Vincent Chin-Hung Chen; Ming-Chih Chou; Roger S McIntyre; Jun-Cheng Weng
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

4.  Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.

Authors:  Alexandra M Gaynor; Anam Ahsan; Duane Jung; Elizabeth Schofield; Yuelin Li; Elizabeth Ryan; Tim A Ahles; James C Root
Journal:  J Cancer Surviv       Date:  2022-08-08       Impact factor: 4.062

5.  Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.

Authors:  Matias Mariani; Mark William Glister Collins
Journal:  Support Care Cancer       Date:  2018-05-17       Impact factor: 3.603

6.  Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study.

Authors:  Michelle C Janelsins; Charles E Heckler; Luke J Peppone; Tim A Ahles; Supriya G Mohile; Karen M Mustian; Oxana Palesh; Ann M O'Mara; Lori M Minasian; Annalynn M Williams; Allison Magnuson; Jodi Geer; Shaker R Dakhil; Judith O Hopkins; Gary R Morrow
Journal:  J Clin Oncol       Date:  2018-09-21       Impact factor: 44.544

7.  Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: the role of encoding versus forgetting.

Authors:  James C Root; Charissa Andreotti; Loretta Tsu; Timothy M Ellmore; Tim A Ahles
Journal:  J Cancer Surviv       Date:  2015-12-12       Impact factor: 4.442

8.  Examining the Association between Patient-Reported Symptoms of Attention and Memory Dysfunction with Objective Cognitive Performance: A Latent Regression Rasch Model Approach.

Authors:  Yuelin Li; James C Root; Thomas M Atkinson; Tim A Ahles
Journal:  Arch Clin Neuropsychol       Date:  2016-04-24       Impact factor: 2.813

9.  Initial encoding deficits with intact memory retention in older long-term breast cancer survivors.

Authors:  Alexandra M Gaynor; Tim A Ahles; Elizabeth Ryan; Elizabeth Schofield; Yuelin Li; Sunita K Patel; Katrazyna McNeal; Tiffany Traina; James C Root
Journal:  J Cancer Surviv       Date:  2021-08-06       Impact factor: 4.062

Review 10.  Cognitive Effects of Cancer and Cancer Treatments.

Authors:  Tim A Ahles; James C Root
Journal:  Annu Rev Clin Psychol       Date:  2018-01-18       Impact factor: 22.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.